EUVIMEDEUVIMED entdecken
Open Access

Influence of postimplant mitral regurgitation on durable left ventricular assist device outcomes

J'undra Pegues, Sina Danesh, Thomas M Cascino, Jennifer A Cowger, Andrew Rosenbaum, Monica M Colvin, Keith D Aaronson, Jie Yang, Donald S Likosky, Francis D Pagani, Paul C Tang, Michigan Congestive Heart Failure Investigators

The Journal of Thoracic and Cardiovascular Surgery · 2025

DOI: 10.1016/j.jtcvs.2025.06.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2025. Verfasst von J'undra Pegues und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, University of Michigan Frankel Cardiovascular Center, Ann Arbor, Mich. Hauptthemen laut MEDLINE: Heart-Assist Devices, Mitral Valve Insufficiency, Heart Failure, Ventricular Function, Left. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The association of significant postimplant mitral regurgitation (PI-MR) with left ventricular assist device (LVAD) outcomes remains controversial. We investigated PI-MR in the setting of contemporary LVAD therapy. METHODS: The Society of Thoracic Surgeons Intermacs National Database was queried and identified 2858 patients with a fully magnetically levitated centrifugal flow LVAD implanted from 2017 to 2021 who met study inclusion and exclusion criteria. Kaplan-Meir methodology and Cox proportional hazard modeling were used to evaluate the long-term influence of PI-MR on post-LVAD outcomes conditional on surviving 3 months post-LVAD implant. Significant PI-MR was defined as moderate-to-severe MR at the 1- or 3-month follow-up echocardiogram. RESULTS: There were 340 patients with significant PI-MR and 2518 without PI-MR following LVAD implant. Those with significant PI-MR were younger (age 53.2 vs 57.7 years; P < .001), more likely to have a nonischemic cardiomyopathy etiology of heart failure (66.5% vs 51.5%; P < .0001), preoperative moderate-to-severe tricuspid regurgitation (51.5% vs 37.6%; P < .001), and concomitant tricuspid valve replacement/repair (17.1% vs 9.4%; < .001). Of those with preoperative significant MR, 17% (n = 274) had significant PI-MR. Significant PI-MR was associated with worse 2-year survival (88.3% vs 79.5%; P = .008), risk for readmission (hazard ratio, 1.19; P = .032) and subsequent renal failure (hazard ratio, 1.84; P = .014). CONCLUSIONS: Significant PI-MR following contemporary LVAD implant adversely influences long-term survival and readmission. Strategies to prevent or intervene upon significant PI-MR require further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesMitral Valve InsufficiencyHeart FailureVentricular Function, LeftProsthesis ImplantationHumansMaleMiddle AgedFemaleRisk FactorsTreatment OutcomeRetrospective StudiesTime FactorsAgedDatabases, FactualRisk AssessmentAdult

Autor:innen und Institutionen

  • Department of Cardiac Surgery, University of Michigan Frankel Cardiovascular Center, Ann Arbor, Mich.
  • Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
  • Division of Cardiovascular Medicine, University of Michigan Frankel Cardiovascular Center, Ann Arbor, Mich.
  • Division of Cardiovascular Medicine, Henry Ford Health, Detroit, Mich.
  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn.
  • Department of Cardiac Surgery, University of Michigan Frankel Cardiovascular Center, Ann Arbor, Mich; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn. Electronic address: tang.paul2@mayo.edu.

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Pegues, J., Danesh, S., Cascino, T. M., Cowger, J. A., Rosenbaum, A., Colvin, M. M., Aaronson, K. D., Yang, J., Likosky, D. S., Pagani, F. D., Tang, P. C., & Michigan Congestive Heart Failure Investigators (2025). Influence of postimplant mitral regurgitation on durable left ventricular assist device outcomes. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2025.06.019

Vancouver

Pegues J, Danesh S, Cascino TM, Cowger JA, Rosenbaum A, Colvin MM, et al. Influence of postimplant mitral regurgitation on durable left ventricular assist device outcomes. The Journal of Thoracic and Cardiovascular Surgery. 2025. doi:10.1016/j.jtcvs.2025.06.019

BibTeX
@article{Pegues2025,
  author = {Pegues, J'undra and Danesh, Sina and Cascino, Thomas M and Cowger, Jennifer A and Rosenbaum, Andrew and Colvin, Monica M and Aaronson, Keith D and Yang, Jie and Likosky, Donald S and Pagani, Francis D and Tang, Paul C and Michigan Congestive Heart Failure Investigators, Michigan Congestive Heart Failure Investigators},
  title = {Influence of postimplant mitral regurgitation on durable left ventricular assist device outcomes},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2025},
  doi = {10.1016/j.jtcvs.2025.06.019}
}
Kostenlos starten →